Johnson & Johnson
JNJ · NYSE · Healthcare
$259.24+0.88%
- Major large cap
Why a candidate
Exp 25/100Inflow
Today's read
Johnson & Johnson scores 25 out of 100 on today's InverseOne expectation ranking, 20 of 30 in the US large-cap universe. It sits in the bottom 85% of its one-year price range, a neglected zone. Today's move of +0.88% came with money flowing in, alongside the Healthcare sector. Scores are estimates built from price and volume, a starting point for research rather than a trading signal.
Data basis: 2026-08-10 · For reference only · not advice
Same-sector stocks · Healthcare
Fund-flow signal
Unlock this stock's fund-flow signal and multi-day trend
- Today's net money flow and signal grade
- Money-flow rank within the market and sector
- 7-day flow trend and streak
- Overlapping combo readings
Today's data for this stock is ready
Name · deep signal · 7-day trend · trade
Market data
- Volume
- 6.4M
- Market cap
- $624.7B
- 52-week range
- $171.81 – $274.90
- P/E
- 30.0
- P/B
- 7.44
- Dividend yield
- 2.00%
52-week position85/100
$171.81$274.90
Upside to 52w high+6.0%
Related news
- Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested in the Dividend King Pays Annually.fool.com · 2026-08-09
- Why PG, JNJ, and KO Could Surprise Investors Next Year247wallst.com · 2026-08-08
- Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of Lawsuitsfinance.yahoo.com · 2026-08-07
Same-sector stocks
These figures are reference estimates built from price and volume: a starting point for narrowing down ideas, not a buy or sell signal.